Healthcare Industry News: immune globulin
News Release - January 27, 2006
MedAssets Names Blood Diagnostics, Inc. as an Awarded Blood Fraction Distributor
IRMO, SC--(Healthcare Sales & Marketing Network)--Jan 27, 2006 -- Blood Diagnostics, Inc., a national provider of plasma-derived pharmaceuticals, announced today the company has entered into a multi-year contract with MedAssets Supply Chain Systems to become its newest blood fraction distributor. Effective in the 2006 contracting period, Blood Diagnostics, Inc. will provide albumin, intravenous immune globulin, coagulation factors VII, VIII, and IX, and hyper-immune and injectable products to MedAssets customers.About MedAssets
MedAssets, headquartered in Atlanta, Georgia, improves healthcare providers' margin and cash flow through revenue cycle and supply chain initiatives and decision support technology and services. As a strategic business partner, MedAssets can replace multiple vendors and decrease supply costs by 3-10 % and increase net patient revenue by 1-3 %. MedAssets Net Revenue Systems provides best-of-breed revenue solutions including strategic pricing, pre-bill charge capturing, and ongoing chargemaster management tools, all of which have been Peer Reviewed by the Healthcare Financial Management Association. MedAssets Net Revenue Systems also offers denials management and a tool to link supply cost data with charge data. MedAssets Supply Chain Systems is one of the fastest growing group purchasing organization in the U.S. and builds customized solutions encompassing procurement of common medical supplies, pharmaceuticals, physician preference supplies, food and nutrition items, and capital equipment. The newly formed MedAssets Analytical Systems offers supply chain analytics and decision support tools while clinical and operational consulting services are provided through MedAssets' subsidiary, Aspen Healthcare Metrics. Avega Health Systems, a subsidiary of MedAssets, ranked "Best in KLAS" in Business Decision Support - KLAS Enterprises, LLC 2005. For more information about MedAssets go to www.medassets.com or contact Gary Johnson, corporate senior vice president of Marketing and Marketing Services, 100 North Point Center East, Suite 200, Alpharetta, GA 30022.
About Blood Diagnostics, Inc.
Blood Diagnostics, Inc. is an independent, wholesale distributor of plasma-derived pharmaceuticals. Over the past decade, the company has built an excellent reputation with its customers as a reliable source for products and service. Blood Diagnostics has represented the complete line of products derived from human plasma, as well as products derived from recombinant technology, to medical facilities throughout the United States since 1995. Blood Diagnostics specializes in Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VII, VIII and IX, as well as hyper-immunes and injectable products. Blood Diagnostics is authorized as a distributor for all of the major plasma derivative manufacturers, is fully insured and fulfills the licensing requirements in all 50 states. With distribution centers located on both coasts, Blood Diagnostics offers prompt shipping as well as emergency delivery service.
Blood Diagnostics was founded on the principles of professional integrity, customer service and commitment to the plasma industry. Emergency 24 / 7 availability, unparalleled customer service, and extensive product knowledge define its customer-centric approach to serving the nation's healthcare community. The company serves as a free source for reference material and market data, offering healthcare providers the latest information on products, supply shortages and other industry events. Blood Diagnostics' promotional literature and web site serve as open-access educational resources, contributing to the promotion of the industry and the education of both the healthcare community and general populace. Visit www.ivig.com for more information regarding Blood Diagnostics' services and products.
Source: Blood Diagnostics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
